Nuveen Asset Management LLC Sells 97,232 Shares of Cardinal Health, Inc. (NYSE:CAH)

Nuveen Asset Management LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 11.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 769,944 shares of the company's stock after selling 97,232 shares during the quarter. Nuveen Asset Management LLC owned 0.32% of Cardinal Health worth $91,061,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Cyrus J. Lawrence LLC purchased a new stake in shares of Cardinal Health during the fourth quarter valued at $26,000. Promus Capital LLC purchased a new stake in Cardinal Health during the fourth quarter valued at about $30,000. Bellwether Advisors LLC acquired a new position in shares of Cardinal Health in the fourth quarter worth about $32,000. Lee Danner & Bass Inc. acquired a new position in shares of Cardinal Health in the fourth quarter worth about $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health during the 4th quarter valued at $36,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of NYSE CAH traded up $0.85 during trading hours on Tuesday, hitting $154.71. 1,928,825 shares of the company's stock were exchanged, compared to its average volume of 2,229,443. The company's 50-day moving average price is $137.63 and its 200-day moving average price is $128.19. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $156.44. The stock has a market capitalization of $36.93 billion, a price-to-earnings ratio of 28.86, a PEG ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The company had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same period in the previous year, the company earned $2.08 earnings per share. The company's quarterly revenue was up .0% compared to the same quarter last year. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.32%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CAH shares. Mizuho boosted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Morgan Stanley raised their price objective on shares of Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. UBS Group lifted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research note on Tuesday, April 29th. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Finally, StockNews.com raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $146.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.